Announcements Trials

Browse Landscape

Status

Completed 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 4 Nasopharyngeal Carcinoma 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Barrett Esophagus 2 Urogenital Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Pathologic Complete Response 1 Paranasal Sinus Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Lung Neoplasms 1 Locally Advanced Pancreatic Cancer 1 Jaw Cysts 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Bacteremia 1

Interventions

Oxaliplatin 42 Fluorouracil 27 Capecitabine 24 pembrolizumab 21 S 1 (combination) 19 Paclitaxel 19 Leucovorin 16 Nivolumab 13 sintilimab 12 Drug Therapy 12 Docetaxel 12 tislelizumab 11 Trastuzumab 10 Cisplatin 10 Irinotecan 8 Bevacizumab 8 trastuzumab deruxtecan 7 spartalizumab 7 fludarabine 7 XELOX 7 Surgical Procedures, Operative 7 Radiotherapy 7 Cyclophosphamide 7 Biopsy 7 disitamab vedotin 6 Hyperthermic Intraperitoneal Chemotherapy 6 lenvatinib 5 apatinib 5 Specimen Handling 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × Endoscopy × Clear all

NCT04809025 2025-09-29

EBPS

Fudan University

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡